Annexin Pharmaceuticals AB (publ) (ANNX)
Market Closed
15 Oct, 03:25 PM
XSTO 
XFRA Primary XSTO kr
7. 84
-0.02
-0.2545%
kr
- Market Cap
- P/E Ratio
- Div Yield
1,442 Volume
- Eps
kr 7.86
Previous Close Want to track ANNX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Annexin Pharmaceuticals AB (publ) (ANNX) Statistics
Valuation metrics
Market Cap -
Enterprise value 59.79M
Trailing P/E (ttm) -1.94
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) -
Price/Book (mrq) 25.4
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.88K
Average volume (90 days) 8.98K
Price summary
52-Week low 11.65
52-Week high 39
Beta -
50-Day moving average 11.49
200-Day moving average 12.85
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 28 May 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -5.32%
Return on equity -2.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.75
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.19%
Book value per share (mrq) 0.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
